~0 spots leftby Apr 2025

Virtual Education Program for Atrial Fibrillation

Recruiting in Palo Alto (17 mi)
+2 other locations
Overseen byAnil Gehi, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of North Carolina, Chapel Hill
No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this study is to determine the effectiveness of a direct-to-patient virtual education program ("AF at Home") for adults with atrial fibrillation (AF). The main questions this study aims to answer are: 1. Will participants in the educational program have improvement in quality of life, self-monitoring, and self-management strategies after program completion? 2. Will patient level quality of AF care improve for participants in the educational program? Participants will be asked to: * Participate in six hours of virtual education sessions over three weeks via Zoom. * Complete online questionnaires before the program starts and after its completion.

Eligibility Criteria

This trial is for adults with atrial fibrillation, either non-valvular or valvular. Participants must be 18 years or older and capable of giving informed consent. It's not open to individuals who are incarcerated.

Inclusion Criteria

I have been diagnosed with atrial fibrillation not caused by heart valve issues.
I am 18 years old or older.

Exclusion Criteria

I am unable to understand and agree to the study's details on my own.
Incarcerated patient

Participant Groups

The 'AF at Home' program is being tested to see if it improves quality of life and self-care in people with atrial fibrillation. Participants will attend six hours of virtual education over three weeks and complete questionnaires before and after the program.
1Treatment groups
Experimental Treatment
Group I: AF at HomeExperimental Treatment1 Intervention
All recruited participants will participate in the AF at Home educational intervention.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of North Carolina, Chapel HillChapel Hill, NC
Duke UniversityDurham, NC
Wake Forest UniversityWinston-Salem, NC
Loading ...

Who Is Running the Clinical Trial?

University of North Carolina, Chapel HillLead Sponsor
Bristol-Myers Squibb FoundationCollaborator
Bristol-Myers SquibbIndustry Sponsor
Wake Forest UniversityCollaborator
Duke UniversityCollaborator

References